Login Start free

Focus

Drug Discovery Investors: Angels and VC Firms

The RaiseHunt database lists 4,683 Drug Discovery investors: 239 angel investors and 4,444 people at 1,313 firms. Most list Seed and Series A among their stages; the largest hubs are New York, San Francisco and Boston.

Strongest in New York, San Francisco and Boston

Common stages: Seed and Series A

4,683: Drug Discovery investors
239: Angel investors
4,444: People at VC/PE firms
1,313: Firms tagged

Skip the browsing. Let AI find your ideal investors in one minute.

Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.

4,683 Drug Discovery investors

Showing 621-640

Filters

Viewing

Drug Discovery4,683

Investor Type

Choosing one replaces Drug Discovery.

Investment Stage

Choosing one replaces Drug Discovery.

Seed84,745
Series A53,997
Late-Stage37,937
Series B35,865
Growth34,738
Pre-Seed32,477

Investment Profile

Choosing one replaces Drug Discovery.

SaaS63,483
FinTech54,183
Healthcare53,462
Consumer46,735
AI46,189
Hardware36,507
Commerce32,773
Climate23,313
Real Estate17,905
Education13,608
Food10,848
Travel7,450
Energy946
Agriculture555

Country

Choosing one replaces Drug Discovery.

City

Choosing one replaces Drug Discovery.

Focus1

Investor	Location	Type	Markets	Contact	Actions
Francis Ping 朗盛投资 at Lang Sheng Investment	Shanghai, China	Venture capital	AIHealthcare		View profile
Benjamin Esmilaire Associate Investor at Lombard Odier Group	Geneva, Switzerland	Family Office	ClimateFinTech		View profile
Shefali Sanghi Strategy Consultant at Thynk Ventures	New York, United States	Venture capital	AIClimate		View profile
Duckie Boon Affiliated at Shanghai Pharmaceutical	Shanghai, China	Corporate VC	Healthcare		View profile
Nicole Zhang Investor at Witruth Capital	Shanghai, China	Family OfficePrivate equity	Healthcare		View profile
Rajat Agarwal Founder in Residence at Entrepreneurs First	Bengaluru, India	AcceleratorVenture capital	AIHardware		View profile
Manav Sevak Investor at Sanofi	New York, United States	Corporate VC	AIHealthcare		View profile
Kurt Voegt Assistant Manager of Investor Services at Platinum Asset Management	Sydney, Australia	Venture debt	AIHealthcare		View profile
Felix S. Co-Founder bei Memogic at Bayer	Wuppertal, Germany	Corporate VC	ClimateFood		View profile
Giulia Crastolla Investor at Nutreco	Utrecht, Netherlands	Corporate VC	FoodHealthcare		View profile
Yeongho Jo Director, Venture Capitalist at SBI Investment	South Korea	Private equityVenture capital	AIHardware		View profile
Quentin Laroche Venture Partner at Amplitude Ventures	Paris, France	Venture capital	AIHealthcare		View profile
Jingjing Li JITRI at Jiangsu Industrial Technology Research Institute	Nanjing, China	Government-backed	ClimateFood		View profile
Xinjia Zou Affiliated at K2vc	Hangzhou, China	Venture capital	AIClimate		View profile
Lucy O'Byrne Investor at Wellcome Trust	London, United Kingdom	Government-backed	AIHealthcare		View profile
Alyssa N. Investor at Yale Ventures	New Haven, United States	Accelerator	ClimateHealthcare		View profile
Hermosa Kang Venture Capital at New Enterprise Associates (NEA)	Côte d'Ivoire	Venture capital	AICommerce		View profile
Hongwei Dong PhotonFund at Photon Fund	United States	Venture capital	ClimateConsumer		View profile
Cate Azais Founder at Entrepreneurs First	London, United Kingdom	AcceleratorVenture capital	AIHardware		View profile
Juan Pablo Orlov Associate at GRIDX	Montevideo, Uruguay	AcceleratorVenture capital	Healthcare		View profile

Data: RaiseHunt investor dataset · Snapshot 26 September 2026 · How this data is built · Report a correction or request removal